Original Articles Open access

Nailfold videocapillaroscopy as a diagnostic clue in interstitial lung disease: differentiating idiopathic from autoimmune patterns in a Caucasian cohort

Authors

Published
21 October 2026
Issue
Early Access
Section
Original Articles
DOI
10.4081/reumatismo.2026.2398

Abstract

Objective. Interstitial lung diseases (ILDs) include idiopathic pulmonary fibrosis (IPF) and autoimmune-related forms such as interstitial pneumonia with autoimmune features (IPAF) and connective tissue disease-associated ILD (CTD-ILD). Nailfold videocapillaroscopy (NVC) is well established in systemic sclerosis (SSc) but remains underused in ILD characterization. This study aimed to evaluate NVC findings in IPF, IPAF, and CTD-ILD.

Methods. This cross-sectional study included 67 Caucasian ILD patients (16 IPF, 13 IPAF, and 38 CTD-ILD, including 21 SSc-ILD). NVC was performed using a digital videocapillaroscope and scored semi-quantitatively (0–3) across six parameters (total score 0–18). Patterns were classified as normal, nonspecific abnormalities, or scleroderma pattern (early, active, or late). Continuous variables were analyzed with one-way analysis of variance and Bonferroni correction; categorical variables with χ² or Fisher’s exact test.

Results. The total NVC score increased progressively from IPF (3.2±1.4) to IPAF (4.5±3.2) and CTD-ILD (6.5±3.1; p=0.001). Capillary loss was the only item of NVC significantly different among groups (p=0.006), although all items showed a gradual increase across the spectrum. Scleroderma patterns were observed in 6.3% of IPF, 23.1% of IPAF, and 65.7% of CTD-ILD patients, particularly in SSc-ILD (95.2%). Notably, 81.3% of IPF patients showed nonspecific abnormalities, suggesting subtle microvascular involvement even in idiopathic disease.

Conclusions. NVC demonstrates potential discriminatory value between IPF and autoimmune-related ILD, especially SSc-ILD. The progressive increase in microvascular abnormalities observed from IPF to SSc-ILD suggests a possible contribution of immune-mediated microvascular involvement across different ILD phenotypes. These findings should be considered exploratory and warrant confirmation in larger prospective studies.  NVC may represent a useful adjunct to serological and radiological assessment in ILD diagnostic pathways.

Keywords

Ethics Approval

The study was approved by the local Ethics Committee (INflammatory MYositis Registry: study no. 6229, approval no. 84762,2020/11/06).

References

  1. Raghu G, Remy-Jardin M, Myers JL, Richeldi L, Ryerson CJ, Lederer DJ, et al Diagnosis of idiopathic pulmonary fibrosis. An official ATS/ERS/JRS/ALAT clinical practice guideline. Am J Respir Crit Care Med 2018; 198: e44-68. DOI: https://doi.org/10.1164/rccm.201807-1255ST
  2. Oldham JM, Adegunsoye A, Valenzi E, Lee C, Witt L, Chen L, et al Characterisation of patients with interstitial pneumonia with autoimmune features. Eur Respir J 2016; 47: 1767-75. DOI: https://doi.org/10.1183/13993003.01565-2015
  3. Graney BA, Fischer A Interstitial pneumonia with autoimmune features. Ann Am Thorac Soc 2019; 16: 525-33. DOI: https://doi.org/10.1513/AnnalsATS.201808-565CME
  4. Liakouli V, Ciancio A, Del Galdo F, Giacomelli R, Ciccia F. Systemic sclerosis interstitial lung disease: unmet needs and potential solutions. Nat Rev Rheumatol 2024; 20: 21-32. DOI: https://doi.org/10.1038/s41584-023-01044-x
  5. Van Den Hoogen F, Khanna D, Fransen J, Johnson SR, Baron M, Tyndall A, et al. 2013 classification criteria for systemic sclerosis: an American college of rheumatology/European league against rheumatism collaborative initiative. Ann Rheum Dis 2013; 72: 1747-55. DOI: https://doi.org/10.1136/annrheumdis-2013-eular.238
  6. Anghel D, Prioteasă OG, Nicolau IN, Bucurică S, Belinski DO, Popescu GG, et al. The role of nailfold videocapillaroscopy in the diagnosis and monitoring of interstitial lung disease associated with rheumatic autoimmune diseases. Diagnostics 2025; 15: 362. DOI: https://doi.org/10.3390/diagnostics15030362
  7. Fischer A, Antoniou KM, Brown KK, Cadranel J, Corte TJ, du Bois RM, et al An official European Respiratory Society/American Thoracic Society research statement: interstitial pneumonia with autoimmune features. Eur Respir J 2015; 46: 976-87. DOI: https://doi.org/10.1183/13993003.00150-2015
  8. Lundberg IE, Tjärnlund A, Bottai M, Werth VP, Pilkington C, de Visser M, et al 2017 European League Against Rheumatism/American College of Rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups. Ann Rheum Dis 2017; 76: 1955-64. DOI: https://doi.org/10.1136/annrheumdis-2017-212786
  9. Hanke K, Brückner CS, Dähnrich C, Huscher D, Komorowski L, Meyer W, et al Antibodies against PM/Scl-75 and PM/Scl-100 are independent markers for different subsets of systemic sclerosis patients. Arthritis Res Ther 2009; 11: R22. DOI: https://doi.org/10.1186/ar2614
  10. Faghihi‐Kashani S, Yoshida A, Bozan F, Zanframundo G, Rozza D, Loganathan A, et al Clinical characteristics of anti‐synthetase syndrome: analysis from the classification criteria for anti‐synthetase syndrome project. Arthritis Rheumatol 2025; 77: 477-89. DOI: https://doi.org/10.1002/art.43038
  11. Travis WD, Costabel U, Hansell DM, King TE, Lynch DA, Nicholson AG, et al. An official ATS/ERS statement: update of the international multidisciplinary classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Me 2013; 188: 733-48. DOI: https://doi.org/10.1164/rccm.201308-1483ST
  12. Sulli A, Secchi ME, Pizzorni C, Cutolo M. Scoring the nailfold microvascular changes during the capillaroscopic analysis in systemic sclerosis patients. Ann Rheum Dis 2008; 67: 885-7. DOI: https://doi.org/10.1136/ard.2007.079756
  13. Ingegnoli F, Ardoino I, Boracchi P, Cutolo M, EUSTAR co-authors. Nailfold capillaroscopy in systemic sclerosis: Data from the EULAR scleroderma trials and research (EUSTAR) database. Microvascular Research 2013; 89: 122-8. DOI: https://doi.org/10.1016/j.mvr.2013.06.003
  14. Lee SH, Min HK, Kim SH, Kim YW, Yoo KH, Kim HJ, et al Nailfold capillaroscopy findings of interstitial pneumonia with autoimmune features. Korean J Intern Med 2023; 38: 903-11. DOI: https://doi.org/10.3904/kjim.2022.358
  15. Umashankar E, Abdel-Shaheed C, Plit M, Girgis L Assessing the role for nailfold videocapillaroscopy in interstitial lung disease classification: a systematic review and meta-analysis. Rheumatology 2022; 61: 2221-34. DOI: https://doi.org/10.1093/rheumatology/keab772
  16. Gaikwad AV, Lu W, Dey S, Bhattarai P, Haug G, Larby J, et al Endothelial-to-mesenchymal transition: a precursor to pulmonary arterial remodelling in patients with idiopathic pulmonary fibrosis. ERJ Open Res 2023; 9: 00487-2022. DOI: https://doi.org/10.1183/23120541.00487-2022
  17. Hu M, Guan XH, Wang LF, Xu HM, Ke SF, Yuan QY, et al Endothelial CD38-induced endothelial-to-mesenchymal transition is a pivotal driver in pulmonary fibrosis. Cell Mol Life Sci 2024; 82: 30. DOI: https://doi.org/10.1007/s00018-024-05548-x
  18. Caporarello N, Ligresti G. Vascular contribution to lung repair and fibrosis. Am J Respir Cell Mol Biol 2023; 69: 135-46. DOI: https://doi.org/10.1165/rcmb.2022-0431TR
  19. Miossi R, De Souza FHC, Shinjo SK Nailfold capillary changes in adult new-onset dermatomyositis: a prospective cross-sectional study. Clin Rheumatol 2019; 38: 2319-26. DOI: https://doi.org/10.1007/s10067-019-04537-x
  20. Sebastiani M, Triantafyllias K, Manfredi A, Gonzalez-Gay MA, Palmou-Fontana N, Cassone G, et al Nailfold capillaroscopy characteristics of antisynthetase syndrome and possible clinical associations: results of a multicenter international study. J Rheumatol 2019; 46: 279-84. DOI: https://doi.org/10.3899/jrheum.180355

Metrics

Citations and online attention from Dimensions, Altmetric and PlumX.

PlumX Metrics

License

Copyright (c) 2026 the Author(s)

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.